Emcure launches generic Eribulin at 40 percent lower price in India Farhat Nasim4 April 2019 9:30 AM ISTEmcure Pharmaceuticals will manufacture Eribulin at its plant at Hinjewadi in Pune and market it at a cost which will be approximately 40 per cent...
Eisai Pharma launches first-in-class epilepsy treatment Fycompa (Perampanel) in India Ruby Khatun Khatun24 Aug 2017 10:00 AM ISTEisai Pharmaceuticals India Pvt. Ltd, a leading Japanese pharmaceutical company announced the launch of Fycompa (perampanel), a new anti-epileptic...